Publications

5674 Results

INTACT (S/N1806): Phase III Randomized Trial of Concurrent Chemoradiotherapy with or without Atezolizumab in Localized Muscle Invasive Bladder Cancer. Toxicity update on first 213 patients

Authors
P Singh;J Efstathiou;M Plets;S Jhavar;S Delacroix;A Tripathi;S Sachdev;A Jani;A Kirschner;C Tangen;R Bangs;M Joshi;B Costello;I Thompson;F Fang;S Lerner
Journal / Conference
ASTRO Annual Meeting (October 23 - 26, 2022, San Antonio, TX), oral
Year
2022
Research Committee(s)
Genitourinary
Study Number(s)
S1806

Radiotherapy use and locoregional recurrence rates on SWOG S1007

Authors
R Jagsi;W Barlow;W Woodward;E Connolly;D Shumway;C Speers;S Stecklein;H Zhang;P Sharma;L Pusztai;G Hortobagyi;K Kalinsky
Journal / Conference
International Journal of Radiation Oncology, Biology, PhysicsVol. 114Issue 3SupplementS43Published in issue: November 01, 2022; ASTRO Annual Meeting (October 23 - 26, 2022, San Antonio, TX), oral scientific session
Year
2022
Research Committee(s)
Breast
Study Number(s)
S1007

Role of Adjuvant Regional Nodal Irradiation in Locoregionally Advanced Melanoma: A Secondary Analysis of SWOG 1404

Authors
M Bhandari;M Othus;J Kirkwood;V Sondak;A Tarhini;E Sharon;K Grossmann;A Ribas;S Patel;E Wuthrick
Journal / Conference
ASTRO Annual Meeting (October 23 - 26, 2022, San Antonio, TX), oral
Year
2022
Research Committee(s)
Melanoma
Study Number(s)
S1404

Lung-MAP Composite Signature for Immune Checkpoint Inhibitor (ICI) Efficacy in Advanced Squamous Cell Lung Cancer (SCC)

Authors
D Gandara;X Hua;K Tolba;D Fabrizio;L Albacker;S Gaffey;M Montesion;G Oxnard;S Adam;F Hirsch;K Kelly;R Herbst;M LeBlanc;M Wu;M Redman;D Kozono
Journal / Conference
Society for Immunotherapy of Cancer (SITC) (Nov 8-12,2022, Boston, MA), poster
Year
2022
Research Committee(s)
Lung
Study Number(s)
S1400A, S1400I

Can order entry systems improve oncology practice? The TrACER Experience

Authors
S Ramsey;A Bansal;W Barlow;K Arnold;A Bell-Brown;K Watabayashi;K Kreizenbeck;G Lyman;S Sullivan;D Hershman
Journal / Conference
ASCO Quality Care Symposium (September 30 - October 1, 2022, Chicago, IL), poster
Year
2022
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S1415CD

Socioeconomic Deprivation and Patient-Reported Outcomes in Symptom Management Trials for Breast Cancer Patients

Authors
R Vaidya;C Till;NL Henry;M Fisch;D Hershman;J Unger
Journal / Conference
ASCO Quality Care Symposium (September 30 - October 1, 2022, Chicago, IL), poster
Year
2022
Research Committee(s)
Symptom Management and Survivorship
Study Number(s)
S0927, S1200, S1202

Survival Outcomes by Insurance Status for Cancer Patients Treated in Clinical Trials

Authors
J Unger;A Moseley;R Vaidya;H Xiao;M LeBlanc;D Hershman
Journal / Conference
ASCO Quality Care Symposium (September 30 - October 1, 2022, Chicago, IL), poster
Year
2022
Research Committee(s)
Cancer Care Delivery

Computer analysis of nuclear morphology with Multiple Instance Learning Predicts Overall Survival for LN+ Breast Cancer Patients from SWOG S8814: A Blinded Validation Study

Authors
D Shao;W Barlow;H Lu;C Lu;K Albain;L Pusztai;J Rae;D Hayes;A Godwin;A Thompson;A Madabhushi
Journal / Conference
San Antonio Breast Cancer Symposium (December 6-10, 2022, San Antonio, TX), poster #P2-11-11
Year
2022
Research Committee(s)
Breast
Study Number(s)
SWOG-8814

ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA (CHL) PATIENTS WITH A POSITIVE INTERIM-PET DEAUVILLE SCORE 5 AFTER 2 ABVD CYCLES: A POOLED ANALYSIS OF INDIVIDUAL PATIENT DATA OF THREE MULTICENTER TRIALS

Authors
S Viviani;C Pavoni;S Barrington;L Guerra;H Schoder;P Johnson;A Kirkwood;D Stephens;J Friedberg;S Chauvie;M Knopp;M Federico;G Emblad;A Rossi;P Corradini;A Gallamini;A Rambaldi;C Tarella
Journal / Conference
International Symposium on Hodgkin Lymphoma (October 22-24, 2022, Cologne, Germany), poster
Year
2022
Research Committee(s)
Lymphoma
Study Number(s)
S0816

Phase III randomized, placebo-controlled clinical trial evaluating the use of adjuvant endocrine therapy +/- everolimus in patients with high-risk, hormone receptor (HR) positive, HER2-negative breast cancer (BC): SWOG/NRG/Alliance S1207 (NCT01674140)

Authors
M Chavez MacGregor;J Miao;L Pusztai;M Goetz;P Rastogi;P Ganz;E Mamounas;S Paik;H Bandos;W Razaq;A O'Dea;V Kaklamani;A Silber;L Flaum;E Andreopoulou;J Baar;A Wendt;J Carney;P Sharma;J Gralow;D Lew;W Barlow;G Hortobagyi
Journal / Conference
San Antonio Breast Cancer Symposium (December 6-10, 2022, San Antonio, TX), oral
Year
2022
Research Committee(s)
Breast
Study Number(s)
S1207